Back to the main directory
Company Quick Note / Equity
- Quick Note - CIFI Holdings Group (884 HK, Buy) - Margin concern overdone; enlarging landbank by Nomura Research
- Quick Note - Rakus (3923 JP)(Buy) 20/3 Q1 results: better than expected by Nomura Research
- Quick Note - JD.com (JD US, Buy) - Significant beat by Nomura Research
- Quick Note - Puregold Price Club (PGOLD PM, Buy) - Results largely in line; reaffirm Buy by Nomura Research
- Quick Note - LT Group, Inc. (LTG PM, Buy) - 1H19: Tobacco continues driving results by Nomura Research
- Quick Note - Sunny Optical (2382 HK, Buy) - 1H19 earnings conference takeaways by Nomura Research
- Quick Note - CYBERDYNE (7779 JP)(Neutral) Q1決算インプレッション by Nomura Research
- Quick Note - 出光興産 (5019 JP)(Buy) æ±ºç®—é€Ÿå ±ï¼šQ1å–¶æ¥åˆ©ç›Šã¯å®Ÿè³ªä¼šç¤¾è¨ˆç”»ç·š by Nomura Research
- Quick Note - Tencent Holdings (700 HK, Buy) - 2Q19: revenue miss, earnings beat by Nomura Research
- Quick Note - KNR Construction (KNRC IN, Buy) - Results miss on delayed Appointed Dates by Nomura Research
- Quick Note - China Unicom (762 HK, Buy) - 1H19:co-sharing is the highlight for CU by Nomura Research
- Quick Note - Alibaba Group Holding (BABA US, Buy) - Impressive earnings beat by Nomura Research
- Quick Note - Ping An (2318 HK, Buy) - Above our forecasts on most key metrics by Nomura Research
- First Look: NVIDIA Corporation (NVDA US, Neutral) - NVDA Earnings: Quick Thoughts Prior to Call by Nomura Instinet Research
- Quick Note - Genting Malaysia Bhd (GENM MK, Buy) - Mgmt should reconsider Empire purchase by Nomura Research
- Quick Note - Asahi Kasei (3407 JP)(Neutral) Osteoporosis treatment Teribone: generic threat subsides by Nomura Research
- ãƒãƒ£ã‚¤ãƒŠãƒ»ãƒ¦ãƒ‹ã‚³ãƒ (Buy)19.12期上期決算 by Nomura Research
- Quick Note - Ujjivan Financial Services (UJJIVAN IN, Reduce) - Ujjivan files for DRHP for the bank by Nomura Research
- Quick Note - Sunway Construction Group Bhd (SCGB MK, Buy) - 1H19 weak; 2H19 to be better by Nomura Research
- Quick Note - Bangkok Chain Hospital (BCH TB, Reduce) - Maintain Reduce for high expectation by Nomura Research
- Quick Note - スシãƒãƒ¼ã‚°ãƒãƒ¼ãƒãƒ«ãƒ›ãƒ¼ãƒ«ãƒ‡ã‚£ãƒ³ã‚°ã‚¹ (3563 JP)(Buy) æ—¢å˜åº—好調ã§ä¸Šæ–¹ä¿®æ£ç™ºè¡¨ by Nomura Research
- Quick Note - Orion (271560 KS, Neutral) - July 2019 sales data by Nomura Research
- Quick Note - Pos Malaysia Berhad (POSM MK, Reduce) - 1QFY20 results review by Nomura Research
- Quick Note: Hilton Grand Vacation (HGV US, Neutral) - M&A Potential: Four Options for HGV by Nomura Instinet Research
- Quick Note - E-MART (139480 KS, Reduce) - E-Mart conference call update by Nomura Research
- Quick Note - NetEase (NTES US, Buy) - NetEase to sell Kaola business reportedly by Nomura Research
- Quick Note: Deciphera Pharmaceuticals, Inc. (DCPH US, Buy) - Pan-Inhibition Pans Out: INVICTUS by Nomura Instinet Research
- Quick Note - Sun Pharmaceutical Industries (SUNP IN, Buy) - 1Q results: earnings ahead of our estimates by Nomura Research
- Quick Note - Ayala Corporation (AC PM, Buy) - First take on 1H19 results by Nomura Research
- Quick Note - Sime Darby (SIME MK, Buy) - Acquires Gough Group for MYR572mn by Nomura Research
- Quick Note - エア・ウォーター (4088 JP)(Neutral) Lindeã®ã‚¤ãƒ³ãƒ‰å—部ガス事æ¥è²·åŽã§åŸºæœ¬åˆæ„ by Nomura Research
- Quick Note - Cyberdyne (7779 JP)(Neutral) 20/3 Q1 results by Nomura Research
- Quick Note - Cebu Pacific (CEB PM, Buy) - 2Q19 results review and analysts’ briefing by Nomura Research
- Quick Note - Air Water (4088 JP)(Neutral) MOU to acquire Linde’s gas operations in Southern India by Nomura Research
- Quick Note - Idemitsu Kosan (5019 JP)(Buy) 20/3 Q1 results: OP in line with guidance on adjusted basis by Nomura Research
- Quick Note - Hong Kong Exchanges and Clearing (388 HK, Buy) - 2Q19 earnings beat despite weak market by Nomura Research
- Quick Note - Apollo Hospitals (APHS IN, Buy) - Q1FY20 results: In line with expectations by Nomura Research
- Quick Note - IPCA Laboratories (IPCA IN, Buy) - 1QFY20 results: ahead of our estimates by Nomura Research
- Quick Note - Dialog Group Berhad (DLG MK, Neutral) - 4Q19/FY19 earnings trump consensus and ours by Nomura Research
- Quick Note - æ—åŒ–æˆ (3407 JP)(Neutral) 骨粗鬆症薬テリボン：ジェãƒãƒªãƒƒã‚¯æ‡¸å¿µå¾Œé€€ by Nomura Research
- 平安ä¿é™ºï¼ˆãƒ”ンアン・インシュアランス）(Buy)19.12期上期決算：大åŠã®æŒ‡æ¨™ãŒä¸ŠæŒ¯ã‚Œ by Nomura Research
- Quick Note - China Aoyuan (3883 HK, Buy) - 1H19 result beat on stronger delivery by Nomura Research
- Quick Note - YY (YY US, Buy) - 2Q19 revenue beat, margin miss by Nomura Research
- Quick Note - Weibo (WB US, Neutral) - Another earnings beat story by Nomura Research
- Quick Note - Baidu (BIDU US, Neutral) - Margin beat in 2Q as did peers by Nomura Research
- Quick Note - Sushiro Global Holdings (3563 JP)(Buy) Upward revisions on brisk same-store sales by Nomura Research
- Quick Note - China Resources Land (1109 HK, Buy) - Earnings upside in FY20/21; top pick by Nomura Research
- Quick Note: Sarepta Therapeutics, Inc. (SRPT US, Buy) - CRL Reason? Competitor NS-065 Tox Data by Nomura Instinet Research
- Quick Note - Xiaomi Corporation (1810 HK, Buy) - 2Q19 better than already bearish sentiment by Nomura Research
- Quick Note - å¤§å’Œå·¥æ¥ (5444 JP)(Neutral) 米国ã®é–¢é€£ä¼šç¤¾ãŒå½¢é‹¼ä¾¡æ ¼ã®å€¤ä¸‹ã’を発表 by Nomura Research